Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.6B | -28.67%2.18B | 9.03%9.72B | 0.96%2.14B | 11.24%3.06B | 25.88%8.91B | -10.27%1.41B | 9.28%2.64B | 10.22%2.12B | 133.99%2.75B |
| Cost of revenue | 2.09B | -30.33%1.67B | 8.91%7.65B | 3.50%1.64B | 11.16%2.4B | 23.81%7.03B | -14.29%1.15B | 9.57%2.13B | 4.75%1.59B | 147.76%2.16B |
| Gross profit | 509.59M | -22.66%511.25M | 9.50%2.06B | -6.66%495.14M | 11.54%661.05M | 34.28%1.88B | 13.45%258.57M | 8.09%501.13M | 30.62%530.49M | 94.65%592.63M |
| Operating expense | 423.47M | 9.36%468.6M | -0.19%1.7B | -7.57%408.84M | 5.94%428.5M | -4.62%1.7B | -9.63%443.22M | -5.47%410.83M | 3.08%442.34M | -5.71%404.49M |
| Operating profit | 86.12M | -81.66%42.65M | 100.09%364.05M | -2.10%86.29M | 23.60%232.55M | 147.74%181.94M | 29.67%-184.65M | 211.17%90.3M | 483.27%88.15M | 251.06%188.14M |
| Net non-operating interest income (expenses) | 3.78M | 258.30%1.6M | 14.60%2.06M | -5.17%422K | -3.46%446K | -19.49%1.8M | -29.92%438K | -34.29%456K | -7.29%445K | 5.48%462K |
| Non-operating interest income | --3.8M | 247.95%1.61M | 15.29%2.13M | -2.88%438K | 0.22%463K | -19.97%1.84M | -27.04%456K | -32.05%475K | -10.34%451K | -3.14%462K |
| Non-operating interest expense | --11K | -23.53%13K | 44.19%62K | 166.67%16K | --17K | -35.82%43K | --18K | 280.00%19K | -73.91%6K | --0 |
| Net investment income | 2.56M | -7.26%3.19M | 28.06%7.04M | -23.87%4.28M | 880.50%3.44M | -40.95%5.5M | -459.18%-1.77M | 1,012.23%2.09M | -14.72%5.62M | -113.49%-441K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 4,227.88%626.29M | 14.47M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 2.83M | -833.78%-16.06M | -102.24%-1.72M | 0 | 97.27%-1.72M | |||||
| Less:Other special charges | ---2.83M | ---- | ---19.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --0 | ---- | 1,960.06%35.43M | ---- | ---- | -97.64%1.72M | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 1.83M | -32.90%259K | -20.87%1.43M | -22.15%341K | -22.18%386K | -48.78%1.8M | -0.96%413K | 9.38%455K | -18.89%438K | -76.88%496K |
| Income before tax | 97.12M | -79.86%47.7M | 383.24%984.81M | 16.22%110M | 25.53%236.82M | 170.46%203.8M | 35.87%-171.1M | 376.77%91.58M | -23.42%94.65M | 267.03%188.66M |
| Income tax | 1.8M | -91.47%3.16M | 47.78%-22.7M | 5.83%27.59M | 77.14%37M | -291.79%-43.47M | -1,758.34%-111.26M | 235.60%20.83M | 98.50%26.07M | 717.13%20.89M |
| Net income | 95.32M | -77.71%44.54M | 307.46%1.01B | 20.17%82.41M | 19.10%199.82M | 179.28%247.26M | 78.12%-59.84M | 280.03%70.75M | -37.91%68.58M | 253.12%167.77M |
| Net income continuous operations | --95.32M | -77.71%44.54M | 307.46%1.01B | 20.17%82.41M | 19.10%199.82M | 179.28%247.26M | 78.12%-59.84M | 280.03%70.75M | -37.91%68.58M | 253.12%167.77M |
| Noncontrolling interests | -189K | 281.80%3.04M | 1,606.43%219.85M | 84.28%-680K | 60.76%-1.67M | -69.72%-14.59M | 47.32%-2.76M | 31.84%-3.26M | -138.76%-4.33M | 56.33%-4.26M |
| Net income attributable to the company | 95.51M | -79.40%41.51M | 200.80%787.66M | 13.97%83.09M | 17.13%201.49M | 186.33%261.86M | 78.72%-57.08M | 314.41%74.01M | -26.58%72.91M | 272.34%172.02M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 95.51M | -79.40%41.51M | 200.80%787.66M | 13.97%83.09M | 17.13%201.49M | 186.33%261.86M | 78.72%-57.08M | 314.41%74.01M | -26.58%72.91M | 272.34%172.02M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.83 | -79.31%0.36 | 200.88%6.8 | 14.29%0.72 | 17.57%1.74 | 186.26%2.26 | 78.88%-0.49 | 316.52%0.64 | -26.37%0.63 | 272.09%1.48 |
| Diluted earnings per share | 0.8241 | -79.31%0.36 | 200.88%6.8 | 13.97%0.717 | 17.57%1.74 | 186.26%2.26 | 78.77%-0.4925 | 314.41%0.6386 | -26.47%0.6291 | 272.09%1.48 |
| Dividend per share | 0 | 0 | 1 | |||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |